Universal Health Services Inc

Finanzen von Universal Health Services Inc (UHS)

$185.100

-2.240 (-1.21%)Zum Schluss

Umsatzquellen von UHS

Universal Health Services, Inc. (UHS) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Managed Care, accounting for 28.7% of total sales, equivalent to $1.23B. Other significant revenue streams include Medicaid and Managed Medicaid. Understanding this composition is critical for investors evaluating how UHS navigates market cycles within the Healthcare Facilities & Services industry.

Profitabilität und Margen von UHS

Evaluating the bottom line, Universal Health Services, Inc. maintains a gross margin of 100.00%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 11.14%, while the net margin is 7.86%. These profitability ratios, combined with a Return on Equity (ROE) of 20.99%, provide a clear picture of how effectively UHS converts its operational activities into shareholder value.

UHS im Vergleich zur Peergroup

In the context of the broader market, UHS competes directly with industry leaders such as PACS and CHE. With a market capitalization of $10.96B, it holds a leading position in the sector. When comparing efficiency, UHS's gross margin of 100.00% stands against PACS's 15.66% and CHE's 30.37%. Such benchmarking helps identify whether Universal Health Services, Inc. is trading at a premium or discount relative to its financial performance.

Finanzielle Entwicklung von Universal Health Services Inc

UHS has shown consistent revenue growth, with Q2 2026 revenue at $4.64 billion and a net income of $364.59 million, reflecting a net margin of 7.86%. The gross margin remains strong at 100%, indicating efficient operations.

Financials

FY2026Q2
YoY:
+8.27%
4.64B
Total Revenue
FY2026Q2
YoY:
+3.28%
516.67M
Operating Profit
FY2026Q2
YoY:
+0.55%
364.59M
Net Income after Tax
FY2026Q2
YoY:
+10.13%
5.98
EPS - Diluted
FY2026Q2
YoY:
-23.78%
215.67M
Free Cash Flow
FY2026Q2
YoY:
0.00%
100.00
Gross Profit Margin - %
FY2026Q2
YoY:
-14.78%
4.67
FCF Margin - %
FY2026Q2
YoY:
-7.09%
7.86
Net Margin - %
FY2026Q2
YoY:
+12.07%
13.56
ROIC

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln